| Financial Year |
March 31 2023 |
| Monetary Funds |
605,452.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
845,500.00 |
| Accounts Receivable |
84,468,324.87 |
| Advances to Suppliers |
11,349,776.65 |
| Other Receivables |
2,825,392.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
31,049,213.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,520.40 |
| Total Current Assets |
154,170,842.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
131,525,517.02 |
| Under-construction Projects |
6,735,415.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,471,813.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
162,732,745.66 |
| Total Assets |
316,903,588.64 |
| Short-Term Loans |
215,022,916.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
863,875.86 |
| Accounts Payable |
23,018,958.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,328,420.04 |
| Taxes Payable |
482,100.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,609,030.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
255,392,041.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
255,392,041.78 |
| Paid-In Capital(Or Share Stock) |
126,673,000.00 |
| Capital Surplus |
188,916,814.63 |
| Surplus Reserve |
43,038,103.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-297,116,371.28 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
61,511,546.86 |
| Owner's Equity（Stockholder's Equity） |
61,511,546.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
316,903,588.64 |
